Dealroom.co ·

Faro, which develops data models and AI tools to speed up clinical trials, raised a $37.3M Series B co-led by Merck Global Health Innovation Fund and S32

What's the deal? Faro has raised a $37 million Series B round to develop AI tools aimed at speeding up clinical trials.

AI Biotech Venture Capital

In this story Faro Merck Global Health Innovation Fund S32

Faro, which develops data models and AI tools to speed up clinical trials, raised a $37.3M Series B co-led by Merck Global Health Innovation Fund and S32

Lead Source

Dealroom.co — Faro, which develops data models and AI tools to speed up clinical trials, raised a $37.3M Series B co-led by Merck Global Health Innovation Fund and S32 ↗

How this story grew

Coverage · 0 Discussion · 0

Aug 30Sep 1

More

EZ Newswire: EZ Newswire

FinSMEs: FinSMEs

citybiz: citybiz

RuntimeWire: RuntimeWire

The SaaS News: The SaaS News

WOWTALE: WOWTALE

Related stories

Wall Street Journal: Network Bio, which is developing an AI foundation model from datasets of patient tissue and blood samples created by pooling access to biobanks, raised $50M

GamesBeat: Astromech, which uses genomic data to build predictive AI models of biological change, raised $20M at a $3.8B valuation, bringing its total funding to $60M

Wall Street Journal: Deep Cogito, which develops open-weight models and helps companies build their own specialized AI models, raised a $43M Series A led by TQ Ventures

Endpoints News: Metriport, whose tools help doctors retrieve patient data, raised $26M in Series A and seed funding led by Matrix GP TJ Parker, taking its total raise to $28.4M

SecurityWeek: London- and Boston-based Mindgard, which offers automated AI security and red-teaming tools to help organizations secure AI systems, raised a $30M Series A

Discuss with AI

ChatGPT ↗ Claude ↗

← Back to TechSnif